Literature DB >> 16305594

Interstitial pneumonitis during lamotrigine therapy.

Narayanamoorti Saravanan, Olayiwala Musibay Otaiku, Robert Namushi Namushi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16305594      PMCID： PMC1884893          DOI： 10.1111/j.1365-2125.2005.02493.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Drug-induced lung disease.

Authors:  M Ozkan; R A Dweik; M Ahmad
Journal:  Cleve Clin J Med       Date:  2001-09       Impact factor: 2.321

2.  Multisystem adverse reaction to lamotrigine.

Authors:  J E Schaub; P J Williamson; E W Barnes; P N Trewby
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

3.  The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.

Authors:  F Pisani; G Oteri; M F Russo; R Di Perri; E Perucca; A Richens
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

Review 4.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-03

5.  Sodium valproate acutely inhibits lamotrigine metabolism.

Authors:  A W Yuen; G Land; B C Weatherley; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

Review 6.  Clinical pharmacology of lamotrigine.

Authors:  A W Peck
Journal:  Epilepsia       Date:  1991       Impact factor: 5.864

7.  Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment.

Authors:  Sandeep B Bavdekar; Mamta N Muranjan; Nithya J Gogtay; Vishakha Kantharia; Nilima A Kshirsagar
Journal:  Ann Pharmacother       Date:  2004-08-10       Impact factor: 3.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.